The head of the US agency overseeing the approval of COVID-19 vaccines vowed Monday to move “as quickly as possible’’ to clear them for use — and potentially immunize 20 million Americans in December.
“We’re going to devote everything at the FDA to move as quickly as possible,” Department of Health and Human Services Secretary Alex Azar told CNBC.
Azar hailed drugmaker Moderna’s announcement Monday that its vaccine appears to be nearly 95 percent effective, calling the data “incredible.’’
News of the vaccine came on the heels of Pfizer last week saying clinical trials indicate its own inoculation has a 90 percent success rate.
Between both companies, “We expect to have approximately 40 million doses by the end of this year, so that would allow us to vaccinate 20 million people in December,’’ Azar said.
“And then we hope to have [the] … remaining vaccine manufacturers come online and also begin producing and get approval,’’ he said.